<unk>  is an uncommon benign liver<unk>  that is most commonly associated with oral contraceptive use in women of childbearing age. It is generally asymptomatic, the typical clinical manifestations include spontaneous rupture or hemorrhage leading to acute abdominal pain with progression to hypotension and even death. There are no specific physical examination findings associated with<unk> . It is more commonly seen in western countries where they are exposed to higher doses of oral contraceptive medications. The estimated incidence is 3 per 1,000,000/year and is 3 to 4 per 100,000 with long term oral contraceptive use.<unk> s are classified on the basis of molecular patterns called phenotypic genotypic classification into 04 groups including; HNF1 alpha inactivated<unk> , beta catenin activated<unk> , inflammatory hepatic<unk>  and unclassified type<unk> . The gold standard method for diagnosis of<unk>  is excision biopsy of the liver lesions either by surgery or laparoscopically. There is no specific medical therapy for the<unk> , wait & watch policy is recommended for<unk> s <5 cm following cessation of oral contraceptives. Annual followup with MRI or ultrasound is recommended until menopause. Surgical resection is the treatment of choice for<unk> s that are >5 cm in diameter, that increase in size, lesions with intra tumoral hemorrhage and male patients (irrespective of the<unk>  size). The radiofrequency ablation (RFA) and transcatheter arterial embolization (TAE) may be tried in patients who are poor candidates for surgery.
Hepatocellular adenoma
Fibrolamellar hepatocellular carcinoma
Focal fatty liver
Hepatic hemangioma
Hepatic cysts
Pancreatic islet cell carcinoma
Hepatocellular carcinoma
Fatty liver